Using computer analysis of scar tissue to predict Crohn's disease outcomes
Part of Digestive system clinical trials.
This study uses a computer program to look at scar tissue in biopsy samples from people with Crohn's disease. The goal is to see if the amount of scar tissue is linked to patient history and how the disease progresses over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with Crohn's disease.
- You have a biopsy from your ileum (part of the small intestine) that has been stained to show scar tissue (fibrosis).
- You have not had any digestive tract surgery before the biopsy.
- You have not had any endoscopic interventions (like balloon dilation) for Crohn's disease before the biopsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how bacteria in the gut may affect scarring (fibrosis) in the intestines, especially in people with Crohn's disease. By joining, you may help researchers understand why scarring happens, which could lead to better treatments.
This study uses a special imaging tracer (FAPI) to find scar tissue in the small intestine of people with Crohn's disease. The goal is to see if this scan can help doctors better understand which parts of the intestine are scarred, which may guide treatment decisions.
This study follows children newly diagnosed with Crohn’s disease to see how results from scans and endoscopy (camera scope) relate to outcomes over the first year. It may help doctors choose better early treatment plans and monitor children more effectively.
This study is testing a new imaging method that uses a special PET/MR scan to see how active Crohn's disease is in your bowel. The scan uses a harmless radioactive tracer that attaches to scar tissue, which may help doctors better understand the disease and guide treatment.
This study analyzes your gut bacteria to see if it can predict how well you will respond to Crohn's disease treatments. If you are having a colonoscopy for routine care, you may be eligible.
This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.
Hear when a new Fibrostenotic Crohn's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.